Spreadsheet: a0a8bdf6-da32-4693-b53c-d71032bdb548
Sheet: Sheet1

Supplement 11. Genes-Indicators of Developmental Potential | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6 | Unnamed: 7 | Based on NIA EST Sequences | Unnamed: 9 | Unnamed: 10 | Unnamed: 11 | Unnamed: 12 | Unnamed: 13 | Unnamed: 14 | Unnamed: 15 | Unnamed: 16 | Unnamed: 17 | Unnamed: 18 | Unnamed: 19 | Unnamed: 20 | Unnamed: 21 | Unnamed: 22 | Unnamed: 23 | Unnamed: 24 | Unnamed: 25 | Unnamed: 26 | Unnamed: 27 | Unnamed: 28 | Unnamed: 29 | Unnamed: 30 | Unnamed: 31 | Unnamed: 32 | Unnamed: 33 | Unnamed: 34 | Unnamed: 35 | Unnamed: 36 | Unnamed: 37 | Unnamed: 38 | Unnamed: 39 | Unnamed: 40 | Unnamed: 41 | Unnamed: 42 | Unnamed: 43 | Unnamed: 44 | Unnamed: 45 | Unnamed: 46 | Unnamed: 47 | Unnamed: 48 | Unnamed: 49 | Public ESTs (based on NAP Sequences matching to UniGene by membership or blat search) | Unnamed: 51 | Unnamed: 52 | Unnamed: 53 | Unnamed: 54 | Unnamed: 55 | Unnamed: 56 | Unnamed: 57 | Unnamed: 58 | Unnamed: 59
Group | U Index | Chromosome | Annotation | [NAME] | Symbols | GO Terms | Manual annotation | Unfertilized Egg  (Long) | Unfertilized Egg | [NAME] | 2-cell Embryo  2 | 4-cell Embryo | 8-cell Embryo | 16-cell [NAME] | 3.5-dpc  embryo  (PCR, Regular) | 3.5 dpc Blastocyst (Long) | Embryo part  from 7.5 dpc C57BL/6J | Ectoplacental clone  from  7.5 dpc | 7.5-dpc Embryo | 9.5-dpc Whole Embryo  (Long) | 6.5-dpc Whole Embryo  (Long) | E7.5 Extraembryonic Part | E7.5 [NAME]  (Long) | 8.5dpc whole embryo  (Long) | 12.5-dpc Female Mesonephros | 12.5 dpc male mesonephros | E12.5 Male Mesonephros  (Long) | E13.5 VMB Dopamine Cell  (Long) | Newborn Brain | [NAME] (Long) | [NAME] (Short) | Newborn Ovary | [NAME] | [NAME] | EG Cell  (Long) | ES Cell (LIF-)  1 (Long) | ES Cell (LIF-)  2 (Short) | ES Cell (LIF+)  1 (Long) | ES Cell (LIF+)  2 (Short) | TS Cell  1 (Long) | TS Cell  2 (Short) | MSC (9-15C)  (Long) | MSC (KUSA-A1)  (Long) | Neural Stem Cell ([NAME])  (Long) | Neural Stem Cell (Doublets)  (Long) | HSC (Kit-, Sca1-)  (Long) | HSC (Kit-, Sca1+)  (Long) | HSC (Kit+, Sca1+)  (Long) | HSC(kit+,Sca1-)  (Long) | Adult | [NAME] | Adult-Stemcell | Embryo | Embryo-Stem cell | Fetus | Neonate | NIA | Preimplantation | Tumor
Total Number of ESTs |  |  |  |  |  |  |  | 6885 | 1010 | 1072 | 1255 | 1424 | 1336 | 1559 | 1706 | 7227 | 5 | 1488 | 1552 | 5886 | 5508 | 5193 | 8068 | 4708 | 4304 | 328 | 2928 | 422 | 2774 | 3708 | 628 | 4519 | 2257 | 178 | 7004 | 726 | 613 | 3738 | 490 | 3933 | 1310 | 3952 | 4432 | 7939 | 7170 | 3616 | 3546 | 2921 | 4140 | 1993278 | 122889 | 5750 | 598170 | 89329 | 492160 | 331487 | 381651 | 107443 | 439099
1 | U001142 | 1 | Mus musculus formin 2 (Fmn2), mRNA | Actin-binding FH2;Formin;Proline-rich extensin;Proline-rich region; | Fmn2; | [NAME] binding activi;cytokinesis;development;intracellular signal;nucleus; | cytokine | 3 | 1 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 14 | 0 | 0 | 9 | 0 | 4 | 5 | 13 | 11 | 0
1 | U002819 | 2 |  | [NAME]; |  |  | transcriptional control | 11 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24 | 4 | 0 | 11 | 1 | 7 | 2 | 24 | 10 | 5
1 | U002908 | 2 | Mus musculus RNA-binding region (RNP1, RRM) containing 1 (Rnpc1), mRNA | RNA-binding region RNP-1 (RNA recognition motif); | Rnpc1;Seb4l; | RNA binding activity;nucleic acid binding; | RNA binding | 1 |  | 1 | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 63 | 2 | 0 | 17 | 0 | 42 | 23 | 7 | 15 | 5
1 | U005065 | 4 | Similar to: Mus musculus similar to Hypothetical protein DJ1198H6.2  (LOC194226), mRNA |  |  |  |  | 12 | 1 | 2 | 1 |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23 | 10 | 0
1 | [NAME] | 5 |  |  |  |  |  | 2 |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 6 | 0
1 | U005566 | 5 | [NAME] cDNA 4933428G09 gene (4933428G09Rik), mRNA |  | 4933428G09Rik; |  |  | 2 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 19 | 8 | 0 | 3 | 0 | 8 | 0 | 8 | 9 | 3
1 | U005771 | 5 | Mus musculus LOC231423 (LOC231423), mRNA |  |  |  |  | 24 |  | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51 | 7 | 0
1 | U006114 | 5 | Mus musculus 2'-5' oligoadenylate synthetase 1D (Oas1d), mRNA | 2-5 oligoadenylate synthetase ubiquitin-like domain;PAP/25A core domain; | Oas1d; | ATP binding activity;RNA binding activity;immune response;nucleic acid binding;transferase activity; | RNA binding | 35 | 1 | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 75 | 39 | 0
1 | U006719 | 6 | WEE1 LIKE PROTEIN KINASE | [NAME] protein kinase;Tyrosine protein kinase; |  | ATP binding activity;protein amino acid [NAME] serine/threo;protein [NAME]; | signal transduction | 16 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 36 | 55 | 0
1 | U007588 | 6 |  |  |  |  |  | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 10 | 0
1 | U007835 | 7 | NACHT , LRR AND PYD CONTAINING PROTEIN PYRIN CONTAINING APAF1 LIKE PROTEIN | Leucine-rich repeat;Leucine-rich repeat, ribonuclease inhibitor subtype;Leucine-rich repeat, ribonuclease inhibitor type;NACHT nucleoside triphosphatase;Pyrin domain; |  |  |  | 1 | 2 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 11 | 14 | 0
1 | U010473 | 9 | Mus musculus B-cell translocation gene 4 (Btg4), mRNA | Anti-proliferative protein; | Btg4; |  | cell cycle | 5 | 4 | 1 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 | 1 | 0 | 0 | 0 | 0 | 2 | 25 | 143 | 0
1 | U010751 | 9 | Mus musculus Bcl2-like 10 (Bcl2l10), mRNA | Apoptosis regulator Bcl-2 protein, BH;BCL2-like apoptosis inhibitor; | [NAME]; | anti-apoptosis;apoptosis;apoptosis inhibitor ;apoptosis regulator ;induction of apoptos;integral to membrane;membrane fraction;mitochondrion; | apoptosis | 6 | 3 | 5 |  |  | 2 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 2 | 0 | 2 | 0 | 0 | 4 | 57 | 63 | 0
1 | U010780 | 9 | MOSG PROTEIN. [Source:SPTREMBL;Acc:Q925N9] |  |  |  |  |  | 3 |  | 3 |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 226 | 8 | 0 | 218 | 20 | 96 | 78 | 112 | 109 | 60
1 | U012594 | 11 | Mus musculus growth differentiation factor 9 (Gdf9), mRNA | Inhibin, alpha subunit;Transforming growth factor beta (TGFb); | Gdf9; | cell growth and/or m;cytokine activity;extracellular;extracellular space;growth factor activi; | cytokine | 101 | 1 | 7 |  |  | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8 | 3 | 0 | 1 | 0 | 1 | 1 | 208 | 154 | 0
1 | U014336 | 12 | Mus musculus T-cell leukemia/lymphoma 1B, 1 (Tcl1b1), mRNA | T-cell leukemia/lymphoma (TCL1B) protein; | Tcl1b1; |  | oncogene | 3 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 43 | 0
1 | U014338 | 12 | Mus musculus T-cell leukemia/lymphoma 1B, 3 ([NAME]), mRNA | T-cell leukemia/lymphoma (TCL1B) protein; | [NAME]; |  | oncogene |  | 2 | 2 | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 9 | 0
1 | U015135 | 13 | [NAME] cDNA 2610005H11 gene (2610005H11Rik), mRNA | BED finger; | 2610005H11Rik; | DNA binding activity; | transcriptional control |  | 2 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48 | 3 | 0 | 22 | 0 | 18 | 5 | 13 | 429 | 13
1 | U016635 | 15 | TROPHININ ASSOCIATED PROTEIN TASTIN TROPHININ ASSISTING |  | E130301L11Rik; | carboxypeptidase A a;cell adhesion;cytoplasm;proteolysis and pept; | cell adhesion | 4 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 32 | 0 | 0 | 30 | 4 | 8 | 18 | 11 | 2 | 5
1 | U019177 | 19 | Mus musculus similar to oocyte secretory protein 1; oocyte secretory proetin 1 [Mus musculus] (LOC225923), mRNA |  |  |  |  | 2 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 13 | 0
1 | U019406 | 19 | [NAME] cDNA 1810015H18 gene (1810015H18Rik), mRNA | Zn-finger, RING; | 1810015H18Rik;2700055A20Rik; |  | transcriptional control | 1 | 1 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 93 | 2 | 0 | 45 | 4 | 22 | 10 | 8 | 30 | 4
1 | U023524 | 2 | Mus musculus E2F transcription factor 1 (E2f1), mRNA | Transcription factor E2F/dimerisation partner (TDP); | E2f1; | DNA binding activity;apoptosis;cell cycle;cell cycle regulator;cytoplasm;nucleus;regulation of cell c;regulation of transc;regulation of transc;transcription factor;transcription factor;translation regulato; | transcriptional control | 2 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 31 | 0 | 0 | 16 | 4 | 3 | 10 | 6 | 21 | 5
1 | U023661 | 2 | [NAME] cDNA 4833422F24 gene (4833422F24Rik), mRNA | TWIK-1/TWIK-2 K+ channel; | 4833422F24Rik; | integral to membrane;potassium channel ac;potassium ion transp; | membraine |  | 1 | 4 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 2
1 | U025245 | 4 |  |  |  |  |  | 17 | 2 | 1 |  |  |  | 5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 179 | 139 | 0
1 | U025755 | 4 | Similar to: Mus musculus similar to Hypothetical protein DJ1198H6.2 ([NAME]),  mRNA |  |  |  |  | 69 | 6 | 2 | 3 |  | 2 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 179 | 139 | 0
1 | U026675 | 5 | Mus musculus 2'-5' oligoadenylate synthetase 1E (Oas1e), mRNA | 2-5 oligoadenylate synthetase ubiquitin-like domain;PAP/25A core domain; | Oas1e; | ATP binding activity;RNA binding activity;immune response;nucleic acid binding;transferase activity; | RNA binding | 3 |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 78 | 27 | 0
1 | U026940 | 5 | IMPORTIN ALPHA SUBUNIT KARYOPHERIN ALPHA | Armadillo repeat;Importin alpha-like protein, beta-binding regon; |  | intracellular protei;protein transporter ;protein-nucleus impo; | protein transporter | 4 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 6 | 7 | 0
1 | U027043 | 6 |  |  |  |  |  | 2 | 1 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 11 | 0
1 | U027346 | 6 | [NAME] cDNA A030007L17 gene (A030007L17Rik), mRNA |  | A030007L17Rik; |  |  |  |  | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 34 | 3 | 0 | 2 | 1 | 1 | 16 | 4 | 5 | 1
1 | U027968 | 6 | similar to SIMILAR TO NICE-5 PROTEIN [Homo sapiens] | Ubiquitin-conjugating enzymes; |  | enzyme [NAME] cycle; | Ubiqutin | 103 | 6 | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 218 | 74 | 0
1 | U028105 | 7 | Mus musculus ret finger protein-like 4 (Rfpl4), mRNA | B302, (SPRY)-like;Butyrophylin-like;SPRY-associated domain;SPla/RYanodine receptor SPRY;Zn-finger, RING; | Rfpl4; | [NAME] binding acti; | proteolysis | 15 | 2 | 6 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48 | 71 | 0
1 | U028289 | 7 | NACHT , LRR AND PYD CONTAINING PROTEIN PYRIN CONTAINING APAF1 LIKE PROTEIN | Leucine-rich repeat;Leucine-rich repeat, ribonuclease inhibitor subtype;Leucine-rich repeat, ribonuclease inhibitor type;NACHT nucleoside triphosphatase;Pyrin domain; |  |  |  | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 9 | 0
1 | U028571 | 7 | Mus musculus LOC212249 (LOC212249), mRNA |  |  |  |  |  | 5 | 1 | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 219 | 0
1 | U029877 | 8 | FINGER PROTEIN FINGER PROTEIN TRIPARTITE MOTIF PROTEIN | B302, (SPRY)-like;Butyrophylin-like;SPRY-associated domain;SPla/RYanodine receptor SPRY;Zn-finger, B-box;Zn-finger, RING; |  | intracellular;zinc ion binding act; | proteolysis | 4 |  | 1 |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 28 | 0
1 | U029879 | 8 | Mus musculus ring finger protein 35 (Rnf35), mRNA | B302, (SPRY)-like;Butyrophylin-like;SPRY-associated domain;SPla/RYanodine receptor SPRY;Zn-finger, RING; | Rnf35; |  | proteolysis | 76 | 4 | 4 | 1 |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 159 | 207 | 0
1 | U030361 | 8 |  | RNA-binding region RNP-1 (RNA recognition motif); |  | nucleic acid binding; | RNA binding | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0
1 | U030490 | 9 | Mus musculus folate receptor 4 (delta) (Folr4), mRNA | Folate receptor; | Folr4; | GPI-anchored membran;extrinsic to plasma ;folate transport;folate transporter a;folic acid binding a;integral to plasma m;membrane fraction;milk protein;post-translational m;receptor activity;receptor mediated en;tumor antigen; | membraine | 1 |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 0 | 0
1 | U031350 | 9 | similar to F-BOX PROTEIN FBX12 (FRAGMENT) [Mus musculus] | Cyclin-like F-box; |  |  | proteolysis | 4 |  | 1 | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 | 4 | 0 | 0 | 0 | 0 | 2 | 62 | 21 | 0
1 | U031352 | 9 | Similar to: Mus musculus similar to F-box protein FBX12 [Mus musculus]  (LOC270199), mRNA | Cyclin-like F-box; |  |  | proteolysis | 20 | 1 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 61 | 11 | 0
1 | U031354 | 9 |  | Cyclin-like F-box; |  |  | proteolysis | 2 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 0
1 | U032786 | 11 | RIKEN cDNA 2210021E03 gene |  | 2210021E03Rik; |  |  | 4 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 28 | 2 | 0 | 1 | 0 | 1 | 19 | 16 | 39 | 0
1 | U033749 | 11 | similar to THYRO1000787 PROTEIN [Homo sapiens] | Zn-finger, C2H2 type; |  | nucleus; | transcriptional control | 5 |  | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 26 | 0 | 0 | 0 | 0 | 13 | 45 | 13 | 3 | 4
1 | U034315 | 12 | Mus musculus T-cell lymphoma breakpoint 1 (Tcl1), mRNA | T-cell leukemia/lymphoma (TCL1B) protein;TCL1/[NAME] family; | Tcl1; | cell cortex;microsome;nucleus;pronucleus; | oncogene | 34 | 3 | 8 | 1 |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 2 | 0 | 1 | 6 | 0 | 0 | 89 | 62 | 0
1 | U036681 | 15 | TYPE II HAIR KERATIN. [Source:SPTREMBL;Acc:Q99M74] | Intermediate filament protein;Keratin, type I;Type II keratin; | Krt2-16;Krt2-20; | cell differentiation;cellular_component u;cytoskeleton organiz;ectoderm development;intermediate filamen;positive regulation ;regulation of cell s;structural constitue;structural molecule ; | cytoskeleton | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7 | 0 | 0 | 0 | 0 | 0 | 5 | 2 | 5 | 0
1 | U040017 | Un | Mus musculus oocyte specific homeobox 5 (Obox5), mRNA | Helix-turn-helix motif, lambda-like repressor;Homeobox; | Obox3;Obox5; | DNA binding activity;biological_process u;cellular_component u;molecular_function u;nucleus;regulation of transc;transcription factor; | transcriptional control | 4 | 5 | 2 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 33 | 60 | 0
1 | U041443 | 9 | Mus musculus similar to cytoplasmically polyadenylated oocyte-specific maternal transcript [Mus sp.] (LOC214725), mRNA |  |  |  |  |  | 2 | 3 | 2 |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 226 | 8 | 0 | 218 | 20 | 96 | 78 | 112 | 109 | 60
1 | U041452 | 11 | Mus musculus similar to RIKEN cDNA 2210409E12 [Mus musculus] (LOC217066), mRNA | Ubiquitin domain; |  |  | Ubiqutin |  | 2 | 1 |  |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 0 | 0 | 2 | 0 | 1 | 0 | 39 | 30 | 0
1 | U041650 | 7 |  |  |  |  |  |  | 50 | 1 | 2 |  |  | 9 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0
1 | U041673 | 9 |  |  |  |  |  |  | 22 | 2 | 1 | 1 |  | 10 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0
1 | U042752 | 6 |  |  |  |  |  | 118 | 1 | 2 |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 113 | 29 | 0
1 | U042786 | 7 | CYTOSOLIC PHOSPHOLIPASE A2 | Lysophospholipase, catalytic domain; |  | phospholipase activi;phospholipid catabol; | metabolism | 15 |  | 3 |  |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 | 3 | 0 | 0 | 0 | 0 | 6 | 36 | 107 | 3
1 | U043985 | 15 | Mus musculus similar to polycystic kidney and hepatic disease 1 [Homo sapiens] (LOC271264), mRNA | Cell surface receptor [NAME]/TIG;Parallel beta-helix repeat; |  |  | signal transduction |  |  | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0
1 | U044151 | X | Mus musculus bone morphogenetic protein 15 (Bmp15), mRNA | Inhibin, alpha subunit;Transforming growth factor beta (TGFb); | Bmp15; | cell growth and/or m;cytokine activity;extracellular;extracellular space;glycopeptide hormone;growth factor activi; | cytokine | 4 | 1 | 1 |  |  | 2 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 8 | 0 | 1 | 0 | 2 | 2 | 23 | 95 | 0
2 | U000097 | 1 |  |  |  |  |  | 2 | 6 | 3 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 20 | 0
2 | U007154 | 6 |  |  |  |  |  | 17 | 1 | 1 | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 134 | 3 | 0 | 23 | 1 | 8 | 23 | 73 | 75 | 79
2 | U007967 | 7 | GTP RHO BINDING PROTEIN 1 | BRO1-like domain;PDZ/DHR/GLGF domain;PKN/rhophilin/rhotekin rho-binding repeat; | 1300002E07Rik;D7Ertd784e; | enzyme activity;intracellular;intracellular signal;signal transduction; | signal transduction | 53 | 2 | 1 |  |  | 1 |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 58 | 0 | 0 | 15 | 0 | 21 | 21 | 105 | 83 | 12
2 | U010561 | 9 | Mus musculus cytochrome P450, 11a, cholesterol side chain cleavage (Cyp11a), mRNA | B-class P450;Cytochrome P450;E-class P450, group I;E-class P450, group IV;Mitochondrial P450; | Cyp11a; | C21-steroid hormone ;cholesterol monooxyg;electron transport;mitochondrion;monooxygenase activi; | steroid hormone |  | 1 | 3 | 1 |  |  |  |  |  |  |  |  | 8 |  |  | 3 | 8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 | 10 | 0 | 12 | 0 | 10 | 2 | 18 | 0 | 0
2 | U015387 | 14 |  |  |  |  |  | 19 | 5 | 7 | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 67 | 80 | 0
2 | U020692 | Un | Similar to: Mus musculus 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330016L19 product:unknown EST, full insert sequence |  |  |  |  | 17 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 2 | 0 | 2 | 0 | 0 | 0 | 24 | 7 | 0
2 | U025754 | 4 | Mus musculus expressed sequence AA617276 (AA617276), mRNA |  | AA617276; |  |  | 84 | 1 |  | 6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 166 | 23 | 0
2 | U026996 | 5 | Mus musculus hypothetical protein MGC38133 (MGC38133), mRNA | Lipid-binding START;RhoGAP domain; | MGC38133; |  | signal transduction | 2 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15 | 1 | 0 | 5 | 0 | 3 | 12 | 6 | 11 | 3
2 | U032509 | 11 | Mus musculus hypothetical gene supported by NM_009090; BC002023; D83999 (LOC276805), mRNA | DNA-directed [NAME] polymerase, 30-40 kDa subunit;RNA polymerase, alpha chain, bacterial and organelle; |  | DNA binding activity;DNA-directed RNA pol;nucleus;transcription; | transcriptional control |  | 3 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 96 | 8 | 1 | 41 | 10 | 39 | 43 | 8 | 17 | 25
2 | U040182 | Un | hypothetical RNI-like structure containing protein |  |  |  |  | 29 | 3 | 1 |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 83 | 81 | 0
3 | U000791 | 1 | Mus musculus hypothetical protein MGC32471 (MGC32471), mRNA |  | MGC32471; | Rieske iron-sulfur p;electron [NAME]; | membraine | 28 | 1 | 3 |  |  |  | 7 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  | 61 | 7 | 0 | 7 | 1 | 4 | 18 | 68 | 55 | 11
3 | U002656 | 2 | RESTRICTED EXPRESSION PROLIFERATION ASSOCIATED PROTEIN 100 P100 DIFFERENTIALLY EXPRESSED IN LUNG CELLS 2 DIL 2 TARGETING PROTEIN FOR XKLP2 C20ORF1 PROTEIN C20ORF2 PROTEIN PROTEIN |  | 2610005B21Rik; | ATP binding activity;GTP binding activity;cell proliferation;mitosis;nucleus;spindle; | GTP binding | 8 |  | 1 | 1 |  |  |  |  | 19 |  |  |  | 2 | 1 |  |  | 4 | 1 |  |  |  |  | 1 |  |  |  |  | 6 |  |  | 1 |  | 1 |  | 2 | 1 | 1 |  |  |  |  |  | 101 | 2 | 0 | 55 | 6 | 40 | 40 | 62 | 27 | 27
3 | U004392 | 4 | U4/U6 SMALL NUCLEAR RIBONUCLEOPROTEIN HPRP4 homolog [Homo sapiens] | G-protein beta WD-40 repeat;Splicing factor motif; |  | RNA splicing;mRNA splicing;nucleus;peroxidase activity;peroxidase reaction;pre-mRNA splicing fa; | RNA splicing | 2 |  | 1 |  |  |  |  |  |  |  |  |  | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  | 1 |  |  |  | 1 | 39 | 0 | 1 | 5 | 2 | 11 | 6 | 10 | 6 | 5
3 | U006298 | 5 | Mus musculus deltex 2 homolog (Drosophila) (Dtx2), mRNA | WWE domain;Zn-finger, RING; | Dtx2; | N receptor [NAME] surface recepto;cytoplasm;nucleus;protein binding acti;transcription co-act;transcription from P; | transcriptional control | 19 |  | 2 |  |  |  |  |  |  |  | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  | 3 |  |  |  |  |  | 114 | 7 | 0 | 74 | 7 | 22 | 105 | 48 | 35 | 12
3 | U007230 | 6 | Similar to: Mus musculus LOC232314 (LOC232314), mRNA |  |  | cysteine protease in; | protease inhibitor | 3 |  | 1 | 3 | 1 | 3 | 1 |  |  |  |  |  |  | 2 |  |  |  |  |  | 1 |  |  | 1 |  |  | 1 |  | 2 |  |  |  |  |  |  | 1 |  |  | 2 |  | 7 |  |  | 106 | 3 | 0 | 26 | 2 | 11 | 16 | 43 | 26 | 32
3 | U010741 | 9 | Mus musculus hypothetical protein MGC38960 (MGC38960), mRNA |  | MGC38960; |  |  | 1 | 1 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  | 34 | 0 | 0 | 4 | 0 | 5 | 7 | 10 | 6 | 2
3 | U011057 | 9 | Mus musculus cell division cycle 25 homolog A (S. cerevisiae) (Cdc25a), mRNA | M-phase inducer phosphatase;Rhodanese-like; | Cdc25a; | M phase of mitotic c;cell cycle;hydrolase [NAME] amino acid d;protein tyrosine pho; | signal transduction | 1 | 1 | 1 |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  | 50 | 5 | 0 | 39 | 5 | 29 | 37 | 11 | 8 | 10
3 | U014839 | 13 | Mus musculus spindlin (Spin), mRNA | Spindlin/spermiogenesis-specific protein; | Spin; | cell cycle;cell cycle regulator;development;gametogenesis; | cytoskeleton | 23 | 3 | 1 | 6 |  | 1 | 2 |  |  |  |  |  | 1 |  | 1 |  |  |  |  | 1 |  |  |  |  | 1 |  |  | 3 |  |  | 2 |  | 1 |  |  | 1 | 2 | 1 |  |  |  | 6 | 228 | 3 | 0 | 52 | 9 | 60 | 52 | 96 | 438 | 30
3 | U021856 | 1 | Mus musculus regulator of G-protein signaling 2 (Rgs2), mRNA | Regulator of G protein; | Rgs2; | G-protein coupled re;GTPase activator act;cell cycle;nucleus;signal transducer ac;signal transduction; | signal transduction |  | 2 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 |  |  | 74 | 4 | 3 | 39 | 0 | 29 | 15 | 27 | 34 | 2
3 | U022024 | 1 | [NAME] cDNA 2410003C07 gene (2410003C07Rik), mRNA | Nuf2 family; | 2410003C07Rik; |  | cell cycle | 12 |  | 2 |  |  |  | 1 |  |  |  |  |  | 4 | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  | 1 |  |  |  | 1 |  |  |  |  |  |  |  | 43 | 5 | 0 | 31 | 7 | 5 | 7 | 25 | 19 | 12
3 | U023053 | 2 | 1 AMINOCYCLOPROPANE 1 CARBOXYLATE | 1-aminocyclopropane-1-carboxylate synthase;Aminotransferase, class I and II; |  | 1-aminocyclopropane-;biosynthesis;transaminase activit; | metabolism | 40 | 2 | 2 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 84 | 56 | 0
3 | U023615 | 2 | [NAME] cDNA 3230401D17 gene (3230401D17Rik), mRNA |  | 3230401D17Rik; |  |  |  | 2 | 1 | 1 |  |  | 2 |  |  |  |  |  |  |  |  | 2 |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  | 56 | 12 | 0 | 14 | 5 | 15 | 5 | 17 | 14 | 8
3 | U026479 | 5 | KELCH LIKE PROTEIN | BTB/POZ domain;Kelch motif;Kelch repeat; |  | [NAME] binding activi;membrane;potassium ion transp;protein binding acti;ring canal formation;voltage-gated potass;voltage-gated potass; | membraine | 5 |  | 1 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  | 52 | 9 | 0 | 10 | 1 | 13 | 15 | 23 | 53 | 0
3 | U026640 | 5 | Mus musculus protein kinase, AMP-activated, beta 1 non-catalytic subunit (Prkab1), mRNA | 5-AMP-activated protein kinase, beta subunit, complex-interacting region;Glycoside hydrolase, family 13, N-terminal; | Prkab1; | SNF1A/AMP-activated ;carbohydrate metabol;fatty acid biosynthe;hydrolase activity, ;nucleus;response to stress;signal transduction; | signal transduction | 3 |  | 1 |  | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  | 3 |  |  | 1 |  |  |  |  |  |  | 1 |  |  |  |  | 69 | 0 | 0 | 18 | 1 | 24 | 5 | 15 | 16 | 31
3 | U027200 | 6 | 60S RIBOSOMAL PROTEIN | EGF-like domain;Proline-rich extensin;Proline-rich region;Ribosomal L29e protein; |  | DNA binding activity;intracellular;protein biosynthesis;regulation of transc;ribosome;structural constitue; | ribosomal protein | 1 |  | 1 | 2 |  |  |  |  |  |  |  | 1 |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  | 1 |  | 1 | 11 |  | 15 | 2 | 0 | 4 | 0 | 3 | 4 | 20 | 16 | 2
3 | U028009 | 6 | hypothetical C2 domain containing protein | C2 domain;Synaptotagmin; | 5730419I09Rik; | ATP binding activity;electron transport;electron transporter;membrane;synaptic vesicle;transport;transporter activity; | membraine | 7 | 1 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  | 3 | 4 |  |  |  | 64 | 4 | 0 | 13 | 0 | 13 | 14 | 29 | 33 | 10
3 | U030448 | 9 | Mus musculus baculoviral IAP repeat-containing 2 (Birc2), mRNA | Baculovirus inhibitor of apoptosis protein repeat (BIR);CARD interaction domain;Zn-finger, RING; | Birc2; | anti-apoptosis;apoptosis;apoptosis inhibitor ;apoptosis regulator ;intracellular; | apoptosis | 28 |  | 1 |  |  | 2 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |  | 4 | 2 | 2 |  | 63 | 1 | 0 | 3 | 0 | 5 | 9 | 71 | 23 | 7
3 | U032469 | 11 | HYPOTHETICAL 15.7 KDA PROTEIN (FRAGMENT). [Source:SPTREMBL;Acc:Q99LL1] |  |  |  |  | 7 | 1 | 1 |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 3 |  |  | 37 | 4 | 0 | 8 | 5 | 9 | 4 | 30 | 20 | 23
3 | [NAME] | 11 | NON KINASE CDC42 EFFECTOR PROTEIN | PAK-box/P21-Rho-binding ; |  |  | signal transduction | 14 | 6 |  | 2 |  | 1 |  |  |  |  |  |  | 1 | 1 | 2 |  | 2 |  |  | 1 |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 11 | 4 |  | 3 |  |  | 172 | 3 | 1 | 26 | 1 | 37 | 28 | 83 | 54 | 14
3 | U035453 | 14 | [NAME] cDNA 4921528E07 gene (4921528E07Rik), mRNA | DDHD domain; | 4921528E07Rik; | defense response;heavy metal binding ;integral to membrane;lymphocyte antigen;plasma membrane; | signal transduction | 1 |  | 2 | 2 |  |  |  |  |  |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  | 35 | 20 | 0 | 4 | 0 | 11 | 11 | 17 | 5 | 10
3 | U038206 | 18 | [NAME] cDNA A930014I12 gene (A930014I12Rik), mRNA |  | A930014I12Rik; | nucleic acid binding; |  | 2 |  | 2 | 1 |  |  |  |  |  |  |  |  | 1 | 3 |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 1 |  |  |  |  | 61 | 0 | 0 | 8 | 3 | 7 | 22 | 11 | 29 | 13
3 | [NAME] | X | Similar to: Mus musculus LOC208429 (LOC208429), mRNA |  |  |  |  | 123 | 1 | 1 | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 239 | 79 | 0
3 | U042760 | 6 | KELCH LIKE PROTEIN | BTB/POZ domain;Kelch repeat; |  | protein binding acti; | signal transduction | 8 |  |  | 1 |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13 | 0 | 0 | 10 | 0 | 3 | 3 | 23 | 41 | 1
3 | U043386 | 14 | Mus musculus MAD homolog 4 interacting transcription coactivator 1 (Mitc1), mRNA |  | Mitc1; | TGFbeta receptor sig;cytoplasm;positive regulation ;transcription factor;transcription factor; | transcriptional control | 8 |  | 2 |  |  | 3 |  |  |  |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  | 5 |  |  |  | 1 |  |  |  |  |  | 4 |  |  |  |  | 29 | 3 | 0 | 9 | 0 | 10 | 10 | 25 | 30 | 16
3 | U043854 | 7 | Mus musculus solute carrier family 21 (organic anion transporter), member 11 (Slc21a11), mRNA | Organic anion transporter polypeptide (OATP), C-terminal;Organic anion transporter polypeptide (OATP), C-terminal ;Organic anion transporter polypeptide (OATP), N-terminal; | Slc21a11; | biological_process u;cellular_component u;integral to membrane;ion transport;membrane;molecular_function u;transport;transporter activity; | membraine | 10 |  | 1 |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |  | 4 |  |  |  |  |  | 65 | 1 | 8 | 11 | 0 | 8 | 17 | 33 | 12 | 6